Study: Virus May Pave Way For New Form Of Chemotherapy

04/8/2002 | USA Today

High-doses of a genetically modified strain of adenovirus, a family of cold viruses, has been tested in 35 patients with colon cancer that had metastasized to their livers. Researchers say the high-dose patients survived an average of one year, which is six months longer than expected. "This could be a new form of chemotherapy that kills cancer cells without killing normal ones," says one study author.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC